NEUROMUSCULAR TRANSMISSION PROPERTIES OF OCULAR MUSCLE
NEUROMUSCULAR TRANSMISSION PROPERTIES OF OCULAR MUSCLE
批准号:
6609672
负责人:
HENRY J KAMINSKI
金额:
$19.13万
依托单位国家:
美国
项目类别:
财政年份:
2001
资助国家:
美国
项目状态:
已结题
起止时间:
2001-07-01 至 2005-06-30
关键词:
action potentials binding sites cholinergic receptors electron microscopy electrophysiology extraocular muscle eye movements fluorescence microscopy genetically modified animals laboratory mouse light microscopy membrane channels microelectrodes neuromuscular disorder neuromuscular junction neuromuscular transmission receptor expression sodium channel synaptic vesicles
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The ocular motor system is preferentially compromised by neuromuscular transmission disorders. In the course of normal eye movement, the extraocular neuromuscular junctions are subject to high stimulation rates that would produce transmission failure of other skeletal muscle junctions. We hypothesize that extraocular muscle synapses have structural features and ion channel characteristics that adapt them to high frequencies of stimulation. Despite their ability to maintain reliable neuromuscular transmission, extraocular muscle is predisposed to diseases of neuromuscular transmission. The hallmark of such diseases is a compromise in the safety factor for transmission. The first specific aim characterizes ultrastructural features of extraocular muscle endplates that are known to contribute to the safety factor of other skeletal muscles. The second aim defines the density of acetylcholine receptors and sodium channels, which are primary determinants of the endplate potential. Specific aim three utilizes direct electrophysiological recording to define the quantal content, endplate sodium currents, and safety factor of singly-innervated extraocular muscle fibers. Fulfillment of these aims provides direct structural-functional correlation to understand the mechanisms that allow these junctions to maintain high firing frequencies. The properties that permit the extraocular muscle junctions to withstand extremely fast firing frequencies likely make them susceptible to compromise when disease at the junction develops. The last objective evaluates this hypothesis in evaluation of the pathology of a transgenic mouse model of a neuromuscular transmission disorder by morphological, ion channel, and functional analyses. Through understanding of mechanisms that enhance neuromuscular transmission at extraocular muscle junctions, the possibility exists that methods may be developed to improve transmission at other junctions compromised by neuromuscular transmission disorders. Further, the devastating visual consequences of deranged transmission at ocular muscle junctions could be reversed.
期刊论文(10)
专著(0)
科研奖励(0)
会议论文
Adverse effects of myasthenia gravis on rat phrenic diaphragm contractile performance.
重症肌无力对大鼠膈肌收缩性能的不利影响。
DOI:
10.1152/japplphysiol.01266.2003
发表时间:
2004
期刊:
Journal of applied physiology (Bethesda, Md. : 1985)
影响因子:
--
作者:
[vanLunteren,Erik, Moyer,Michelle, Kaminski,HenryJ]
通讯作者:
Kaminski,HenryJ
DOI:
10.1111/j.1749-6632.2012.06783.x
发表时间:
2012-12
期刊:
Annals of the New York Academy of Sciences
影响因子:
5.2
作者:
[Kusner LL, Kaminski HJ]
通讯作者:
Kaminski HJ
MGNet Administrative Core
-
批准号:10437795
-
项目类别:
-
资助金额:$100.65万
-
财政年份:2019
-
负责人:HENRY J KAMINSKI
-
依托单位:
Rare Disease Network for Myasthenia Gravis
-
批准号:10207810
-
项目类别:
-
资助金额:$149.07万
-
财政年份:2019
-
负责人:HENRY J KAMINSKI
-
依托单位:
Rare Disease Network for Myasthenia Gravis
-
批准号:10437794
-
项目类别:
-
资助金额:$158.9万
-
财政年份:2019
-
负责人:HENRY J KAMINSKI
-
依托单位:
An Open Label Trial of Ixazomib for Treatment Resistant Myasthenia Gravis
-
批准号:10437798
-
项目类别:
-
资助金额:$24.72万
-
财政年份:2019
-
负责人:HENRY J KAMINSKI
-
依托单位:
Rare Disease Network for Myasthenia Gravis
-
批准号:9804343
-
项目类别:
-
资助金额:$161.02万
-
财政年份:2019
-
负责人:HENRY J KAMINSKI
-
依托单位:
Rare Disease Network for Myasthenia Gravis
-
批准号:10005504
-
项目类别:
-
资助金额:$153.16万
-
财政年份:2019
-
负责人:HENRY J KAMINSKI
-
依托单位:
Rare Disease Network for Myasthenia Gravis
-
批准号:10645043
-
项目类别:
-
资助金额:$153.44万
-
财政年份:2019
-
负责人:HENRY J KAMINSKI
-
依托单位:
MGNet Administrative Core
-
批准号:10645044
-
项目类别:
-
资助金额:$103.22万
-
财政年份:2019
-
负责人:HENRY J KAMINSKI
-
依托单位:
An Open Label Trial of Ixazomib for Treatment Resistant Myasthenia Gravis
-
批准号:10645048
-
项目类别:
-
资助金额:$15.79万
-
财政年份:2019
-
负责人:HENRY J KAMINSKI
-
依托单位:
An Open Label Trial of Ixazomib for Treatment Resistant Myasthenia Gravis
-
批准号:10207813
-
项目类别:
-
资助金额:$22.27万
-
财政年份:2019
-
负责人:HENRY J KAMINSKI
-
依托单位:
MGNet Administrative Core
-
批准号:10207811
-
项目类别:
-
资助金额:$94.96万
-
财政年份:2019
-
负责人:HENRY J KAMINSKI
-
依托单位:
Targeted Therapy for Myasthenia Gravis
-
批准号:10004729
-
项目类别:
-
资助金额:$23.28万
-
财政年份:2019
-
负责人:HENRY J KAMINSKI
-
依托单位:
Regulation of Extraocular Muscle Development
-
批准号:7446465
-
项目类别:
-
资助金额:$21.99万
-
财政年份:2004
-
负责人:HENRY J KAMINSKI
-
依托单位:
Regulation of Extraocular Muscle Development
-
批准号:6844605
-
项目类别:
-
资助金额:$37.75万
-
财政年份:2004
-
负责人:HENRY J KAMINSKI
-
依托单位:
Regulation of Extraocular Muscle Development
-
批准号:7060809
-
项目类别:
-
资助金额:$36.86万
-
财政年份:2004
-
负责人:HENRY J KAMINSKI
-
依托单位:
Regulation of Extraocular Muscle Development
-
批准号:7177461
-
项目类别:
-
资助金额:$14.66万
-
财政年份:2004
-
负责人:HENRY J KAMINSKI
-
依托单位:
Targeted Therapies for Myasthenia Gravis
-
批准号:6945146
-
项目类别:
-
资助金额:$82.62万
-
财政年份:2003
-
负责人:HENRY J KAMINSKI
-
依托单位:
Targeted Therapies for Myasthenia Gravis
-
批准号:7287393
-
项目类别:
-
资助金额:$101.89万
-
财政年份:2003
-
负责人:HENRY J KAMINSKI
-
依托单位:
Targeted Therapies for Myasthenia Gravis
-
批准号:6670039
-
项目类别:
-
资助金额:$85.09万
-
财政年份:2003
-
负责人:HENRY J KAMINSKI
-
依托单位:
Targeted Therapies for Myasthenia Gravis
-
批准号:7123807
-
项目类别:
-
资助金额:$123.45万
-
财政年份:2003
-
负责人:HENRY J KAMINSKI
-
依托单位:
海外基金